Filing Details
- Accession Number:
- 0001144204-18-046141
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-23 21:18:10
- Reporting Period:
- 2018-08-21
- Accepted Time:
- 2018-08-23 21:18:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601607 | Bfi Co., Llc | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2018-08-21 | 30,000 | $0.00 | 60,000 | No | 4 | C | Direct | |
Class A Common Stock | Disposition | 2018-08-21 | 10,000 | $50.35 | 50,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2018-08-22 | 10,000 | $49.92 | 40,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2018-08-23 | 10,000 | $49.84 | 30,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Class B Common Stock | Disposition | 2018-08-21 | 30,000 | $0.00 | 30,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,216,034 | No | 4 | C | Direct |
Footnotes
- Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.90 to $50.65, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.65, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.70 to $50.10, inclusive.